SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-005931
Filing Date
2016-05-12
Accepted
2016-05-12 16:40:06
Documents
52
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mirn-20160331x10q.htm 10-Q 1438667
2 EX-31.1 mirn-20160331ex3110b8f1e.htm EX-31.1 18789
3 EX-31.2 mirn-20160331ex312fcd8d3.htm EX-31.2 18259
4 EX-32.1 mirn-20160331ex321e2ab33.htm EX-32.1 11840
  Complete submission text file 0001558370-16-005931.txt   4211447

Data Files

Seq Description Document Type Size
5 EX-101.INS mirn-20160331.xml EX-101.INS 753871
6 EX-101.SCH mirn-20160331.xsd EX-101.SCH 28502
7 EX-101.CAL mirn-20160331_cal.xml EX-101.CAL 31079
8 EX-101.DEF mirn-20160331_def.xml EX-101.DEF 88473
9 EX-101.LAB mirn-20160331_lab.xml EX-101.LAB 269819
10 EX-101.PRE mirn-20160331_pre.xml EX-101.PRE 187674
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744 512-681-5252
Mirna Therapeutics, Inc. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37566 | Film No.: 161644537
SIC: 2834 Pharmaceutical Preparations